Showing results (951-960 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|January 31, 2020
High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer and 4 or More Involved Axillary Lymph Nodes: 20-Year Follow-up of a Phase 3 Randomized Clinical TrialTessa G Steenbruggen, Lars C Steggink, Caroline M Seynaeve, et al.
JAMA Oncology|January 18, 2019
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology PracticesScott D Ramsey, Joseph M Unger, Laurence H Baker, et al.
JAMA Oncology|December 7, 2018
Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical TrialAhmed Salem, Hitesh Mistry, Matthew Hatton, et al.
JAMA Oncology|December 14, 2018
Alpelisib Plus Fulvestrant in PIK3CA-Altered and PIK3CA-Wild-Type Estrogen Receptor-Positive Advanced Breast Cancer: A Phase 1b Clinical TrialDejan Juric, Filip Janku, Jordi Rodón, et al.
JAMA Oncology|November 27, 2018
Emerging Role of Combination Immunotherapy in the First-line Treatment of Advanced Renal Cell Carcinoma: A ReviewSaby George, Brian I Rini, Hans J Hammers
JAMA Oncology|November 27, 2018
Rechallenge for Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer With Acquired Resistance to First-line Cetuximab and Irinotecan: A Phase 2 Single-Arm Clinical TrialChiara Cremolini, Daniele Rossini, Emanuela Dell'Aquila, et al.
JAMA Oncology|January 3, 2020
Stereotactic Ablative Radiotherapy for the Management of Spinal Metastases: A ReviewRachel M Glicksman, Michael C Tjong, Wellington F P Neves-Junior, et al.
JAMA Oncology|December 13, 2019
Overall Survival in Men With Bone Metastases From Castration-Resistant Prostate Cancer Treated With Bone-Targeting Radioisotopes: A Meta-analysis of Individual Patient Data From Randomized Clinical TrialsSafae Terrisse, Eleni Karamouza, Chris C Parker, et al.
JAMA Oncology|January 24, 2020
Objective Response Rate Among Patients With Locally Advanced or Metastatic Sarcoma Treated With Talimogene Laherparepvec in Combination With Pembrolizumab: A Phase 2 Clinical TrialCiara M Kelly, Cristina R Antonescu, Timothy Bowler, et al.
JAMA Oncology|March 28, 2020
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical TrialRyan Phillips, William Yue Shi, Matthew Deek, et al.
Pageof 161